AM2018 Management of Adult Sarcoma

This didactic session on the management of adult sarcoma will provide a comprehensive overview of adult sarcoma diagnoses and updates in molecular genetic profiling, prognostic factors, treatments and outcomes. It will review practice management with emphasis on multi-modality patient assessment, decision making and the respective roles of radiation therapy, surgery and chemotherapy. Areas of controversy, innovation and active clinical research will also be discussed.

Target Audience

The meeting is designed to meet the interests of radiation oncologists, radiation oncology residents, radiation physicists, nurses, radiation therapists, and radiation dosimetrists.

Learning Objectives

  • Describe practice management of adult sarcoma with emphasis on multi-modality patient assessment, decision making, and role of radiation therapy.
  • Discuss technical aspects of radiation treatment planning for patients with sarcoma, with updated discussion of studies of outcomes and state of the published data as to what provides the highest value care and best outcomes for patients with sarcoma.
  • Discuss new innovations in sarcoma diagnosis and management with emphasis on sarcoma molecular-genetic markers and differential management approaches that provide added value for patients with various presentations of these biologically and anatomically diverse disease processes.
Course summary
Available credit: 
  • 1.25 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

Course opens: 
07/24/2018
Course expires: 
11/02/2018
Cost:
$0.00
Rating: 
0

Faculty disclosures all go here as well as the Education Committee disclosure list.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.25 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.

Accreditation Period

Course opens: 
07/24/2018
Course expires: 
11/02/2018

Price

Cost:
$0.00
Please login or register to take this course.

Policies: 
    • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
    • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
    • ASTRO staff cannot make modifications to your submitted materials.
 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.